Hims & Hers buys Zava to form European beachhead
Pharmaphorum
Wed, 06/4/25 - 09:41 am
Hims & Hers Health
UK
M&A
Zava
digital health
Europe
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
BioSpace
Wed, 06/4/25 - 09:39 am
Eli Lily
Camurus
obesity
GLP-1 agonists
ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons
Clinical Trials Arena
Tue, 06/3/25 - 11:03 pm
AbbVie
ASCO 2025
non-small cell lung cancer
telisotuzumab adizutecan
FDA commissioner pledges to investigate mifepristone
The Hill
Tue, 06/3/25 - 11:01 pm
FDA
Marty Makary
abortion pill
mifepristone
ASCO 2025: GSK’s Jemperli fails to show OS benefit in 1L advanced ovarian cancer
Clinical Trials Arena
Tue, 06/3/25 - 10:58 pm
ASCO 2025
GSK
Jemperli
clinical tirals
ovarian cancer
ASCO25: Genmab’s Rina-S en route to ‘blockbuster potential’ amid further positive data
Clinical Trials Arena
Tue, 06/3/25 - 10:54 pm
ASCO 2025
Genmab
Rina-S
endometrial cancer
Bayer drug could ease side effects of common breast cancer treatment, detailed data show
BioPharma Dive
Tue, 06/3/25 - 10:51 pm
Bayer
elinzanetant
hot flashes
ASCO 2025
breast cancer
June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Tue, 06/3/25 - 11:43 am
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech: FT
Fierce Biotech
Tue, 06/3/25 - 11:41 am
Merck
MoonLake Immunotherapeutics
M&A
sonelokimab
ASCO: Sanofi shows investigational Sarclisa SC, delivered by on-body device, measures up to its IV formulation
Fierce Pharma
Tue, 06/3/25 - 11:39 am
Sanofi
Sarclisa SC
JNJ
Darzalex
ASO 2025
Multiple Myeloma
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
Clinical Trials Arena
Tue, 06/3/25 - 11:34 am
Arrowhead Pharmaceuticals
clinical trials
ARO-ALK7
RNAi
obesity
ASCO: OSE shares 65% overall survival rate behind therapeutic cancer vaccine's phase 2 win
Fierce Biotech
Tue, 06/3/25 - 11:14 am
ASCO 2025
OSE Immunotherapeutics
vaccines
pancreatic cancer
clinical trials
Tedopi
Wegovy use up 50% among US teens
Yahoo/Reuters
Tue, 06/3/25 - 11:12 am
Novo Nordisk
obesity
Wegovy
weight loss
teens
Canid secures $10m in funding to transform vaccine management with ai-driven platform that eliminates administrative burden for pediatricians
Businesswire
Tue, 06/3/25 - 11:10 am
Canid
funding
pediatrics
vaccines
artificial intelligence
ASCO: Kura, Kyowa reveal 23% remission rate behind oral leukemia drug's phase 2 win
Fierce Biotech
Tue, 06/3/25 - 10:57 am
Kura Oncology
Kyowa Kirin
ASCO 2025
leukemia
ziftomenib
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Fierce Pharma
Tue, 06/3/25 - 10:52 am
ASCO 2025
Bristol Myers Squibb
Opdualag
skin cancer
melanoma
Regeneron's weight-loss drug combo helps preserve muscle in study
MSN/Reuters
Tue, 06/3/25 - 10:43 am
Regeneron
Novo Nordisk
Wegovy
trevogrumab
obesity
clinical trials
COVID’s remaining biotech contenders navigate a dwindling market
Pharma Voice
Tue, 06/3/25 - 10:40 am
COVID-19
GeoVax
Inflarx
Invivyd
Pemgarda
Amid staff cuts, FDA looks to AI to 'optimize' reviews
Pharmaphorum
Tue, 06/3/25 - 10:38 am
FDA
artificial intelligence
genAI
drug reviews
Clairity Breast Becomes First FDA-Authorized AI to Predict Breast Cancer Using Mammograms
Xtalks
Tue, 06/3/25 - 10:36 am
Clairity
Clairity Breast
breast cancer
FDA
Medtech
artificial intelligence
mammograms

Pages